These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27190545)

  • 21. Pitavastatin decreases plasma prebeta1-HDL concentration and might promote its disappearance rate in hypercholesterolemic patients.
    Kawano M; Nagasaka S; Yagyu H; Ishibashi S
    J Atheroscler Thromb; 2008 Feb; 15(1):41-6. PubMed ID: 18270457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma Levels of Preβ1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease.
    Kuchta A; Ćwiklińska A; Czaplińska M; Wieczorek E; Kortas-Stempak B; Gliwińska A; Dąbkowski K; Sałaga-Zaleska K; Mickiewicz A; Dębska-Ślizień A; Król E; Jankowski M
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the ratio of apoB/apoA-1 the best predictor for the severity of coronary artery lesions in Chinese diabetics with stable angina pectoris? An assessment based on Gensini scores.
    Hong LF; Yan XN; Fan Y; Wu Q; Luo SH; Yang B; Li JJ
    J Geriatr Cardiol; 2015 Jul; 12(4):402-9. PubMed ID: 26346771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women.
    Lamon-Fava S; Herrington DM; Reboussin DM; Sherman M; Horvath KV; Cupples LA; White C; Demissie S; Schaefer EJ; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):575-9. PubMed ID: 18174456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.
    Lagrost L; Gandjini H; Athias A; Guyard-Dangremont V; Lallemant C; Gambert P
    Arterioscler Thromb; 1993 Jun; 13(6):815-25. PubMed ID: 8499401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High density lipoproteins and reverse cholesterol transport: lessons from mutations.
    von Eckardstein A; Assmann G
    Atherosclerosis; 1998 Apr; 137 Suppl():S7-11. PubMed ID: 9694535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
    Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
    Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre beta 1-high-density lipoprotein increases in coronary artery disease.
    Miida T; Nakamura Y; Inano K; Matsuto T; Yamaguchi T; Tsuda T; Okada M
    Clin Chem; 1996 Dec; 42(12):1992-5. PubMed ID: 8969638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in apolipoprotein E-containing high-density lipoprotein (HDL) have little impact on HDL-cholesterol measurements using homogeneous assays in normolipidemic and dyslipidemic subjects.
    Sasamoto K; Hirayama S; Kon M; Seino U; Ueno T; Nagao Y; Hirayama A; Isshiki M; Idei M; Yano K; Miida T
    Clin Chim Acta; 2017 Jul; 470():56-63. PubMed ID: 28442245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
    Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
    Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in alpha1 HDL concentration predicts progression in coronary artery stenosis.
    Asztalos BF; Batista M; Horvath KV; Cox CE; Dallal GE; Morse JS; Brown GB; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):847-52. PubMed ID: 12637338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.
    Liao D; Tan H; Hui R; Li Z; Jiang X; Gaubatz J; Yang F; Durante W; Chan L; Schafer AI; Pownall HJ; Yang X; Wang H
    Circ Res; 2006 Sep; 99(6):598-606. PubMed ID: 16931800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.
    Tornvall P; Karpe F; Proudler A; Båvenholm P; Landou C; Olivecrona T; Hamsten A
    Metabolism; 1996 Nov; 45(11):1375-82. PubMed ID: 8931642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density lipoprotein particles are large in patients with variant angina.
    Miwa K; Yoshida N; Nakagawa K; Inoue H
    Cardiovasc Res; 1998 Mar; 37(3):729-37. PubMed ID: 9659457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease.
    Romm PA; Green CE; Reagan K; Rackley CE
    Am J Cardiol; 1991 Mar; 67(6):479-83. PubMed ID: 1671804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.